论文部分内容阅读
目的对利用舒利迭药物吸入治疗支取管哮喘的临床效果进行探讨。方法选择我院支气管哮喘患者86例,随机将86例患者平均分为治疗组与对照组。两组患者均确诊为支气管哮喘,对照组采用支气管扩张剂的基础治疗法,在此基础上,治疗组加用舒利迭药物吸入治疗,治疗后对两组患者的临床治疗情况等相关评价指标进行比较分析。结果治疗组的总有效率为95.35%(41/43),治疗后肺功能明显改善,患者第一秒用力呼气容积(FEV1)和用力呼气峰流速(PEF)值占估计值的百分比均显著提高,差别均具有统计学意义(P<0.05)。而对照组的总有效率为74.42%(32/43),两组比较治疗组效果更优。结论采用舒利迭药物吸入治疗支气管哮喘,有较好的临床疗效,值得在临床上推广应用。
Objective To explore the clinical effect of using seretide inhalation in the treatment of bronchial asthma. Methods Eighty-six patients with bronchial asthma in our hospital were randomly divided into treatment group (86 cases) and control group (86 cases). Two groups of patients were diagnosed as bronchial asthma, the control group with bronchodilator basic treatment, on this basis, the treatment group with the use of seretide drug inhalation, after treatment, the two groups of patients with clinical evaluation of related indicators For comparative analysis. Results The total effective rate was 95.35% (41/43) in the treatment group. The pulmonary function improved significantly after treatment. The mean values of FEV1 and PEF in both groups were Significantly improved, the difference was statistically significant (P <0.05). The total effective rate of the control group was 74.42% (32/43), the two groups were better than the treatment group. Conclusions The use of seretide inhalation in the treatment of bronchial asthma, has a good clinical efficacy, it is worth to promote the clinical application.